Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 47 entries
No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
F2
💬1. F2
| [8] Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer [8] Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagu ... | Thrombomodulin alfa
Thrombomodulin alfa
💬1. F2
| Thrombomodulin Alfa | [1] 85 85 💬1. F2
| ||||||||||||
2 |
F2
💬2. F2
| [8] Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer [8] Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagu ... | Dabigatran etexilate
Dabigatran etexilate
💬2. F2
| Dabigatran etexilate | [2] 51 51, 75 💬
| ||||||||||||
3 |
F2
💬3. F2
| [8] Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer [8] Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagu ... | Dabigatran
Dabigatran
💬3. F2
| Dabigatran | [5] 51 51, 75, 85, 91, 124 💬
| ||||||||||||
4 |
F8
💬4. F8
| [1] Complement and coagulation cascades Complement and coagulation cascades | Desmopressin
Desmopressin
💬4. F8
| Desmopressin | [6] 6 6, 64, 72, 75, 225, 288 💬
| ||||||||||||
5 |
F9
💬5. F9
| [1] Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬5. F9
| Emicizumab | [1] 288 288 💬5. F9
| ||||||||||||
6 |
F10
💬6. F10
| [1] Complement and coagulation cascades Complement and coagulation cascades | Apixaban
Apixaban
💬6. F10
| Apixaban | [1] 222 222 💬6. F10
| ||||||||||||
7 |
F10
💬7. F10
| [1] Complement and coagulation cascades Complement and coagulation cascades | Rivaroxaban
Rivaroxaban
💬7. F10
| Rivaroxaban | [4] 46 46, 49, 91, 210 💬
| ||||||||||||
8 |
F10
💬8. F10
| [1] Complement and coagulation cascades Complement and coagulation cascades | Edoxaban
Edoxaban
💬8. F10
| Edoxaban | [2] 46 46, 88 💬
| ||||||||||||
9 |
F10
💬9. F10
| [1] Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬9. F10
| Emicizumab | [1] 288 288 💬9. F10
| ||||||||||||
10 |
FCER1A
💬10. FCER1A
| [4] Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathway, Asthma [4] Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathw ... | Omalizumab
Omalizumab
💬10. FCER1A
| Omalizumab | [7] 46 46, 53, 65, 98, 162, 226, 299 💬
|